Fragile X Syndrome


Fragile X syndrome is one of the most common inherited causes of intellectual disability, right below Down syndrome. How are basic science findings being translated into treatments for patients with neurodevelopment disorders, like Fragile X syndrome?

Tetra Therapeutics recently announced positive results from its Phase II exploratory study in adult patients with Fragile X syndrome.

But what is Fragile X syndrome, and what other research has been conducted around this neurodevelopmental disorder?

Elizabeth Berry-Kravis, MD, PhD, explains.

Dr Berry-Kravis is a pediatric neurologist at Rush University Medical Center.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2024 MJH Life Sciences

All rights reserved.